Vaginal and Perineal Plastic Surgery (Perineoplasty / Vaginoplasty) — Cost, Top Hospitals & Success Rates | MyMedicPlus

Vaginal and perineal plastic surgery encompasses a group of reconstructive and functional surgical procedures aimed at restoring normal anatomy and function of the vaginal canal and perineum — the anatomical region between the vaginal opening and the anus. The most frequently performed procedures in this category are perineoplasty (reconstruction of the perineal body) and posterior vaginoplasty (surgical repair and tightening of the posterior vaginal wall and its support structures).

These procedures address a spectrum of functional conditions, including perineal disruption and laxity following vaginal childbirth, symptomatic introital stenosis (abnormal narrowing of the vaginal opening) from scarring, radiation injury, or lichen sclerosus, and structural contributions to dyspareunia (painful intercourse) and vaginismus (involuntary vaginal muscle spasm).

The perineal body is a fibromuscular structure at the perineal centre between the vaginal fourchette and the anal verge. It serves as an anchor for eight pelvic floor muscles including the bulbocavernosus, superficial and deep transverse perineal muscles, and the external anal sphincter. Disruption of the perineal body — most commonly during vaginal delivery by a perineal tear (second, third, or fourth degree) or episiotomy — weakens the structural foundation of the posterior vaginal compartment, causing a deficient, patulous perineum, loss of the normal perineal body, and separation of the fourchette.

It is important to distinguish these functionally and anatomically indicated procedures — which address documented injury, structural deficiency, or genuine functional impairment — from elective cosmetic procedures marketed under terms such as 'vaginal rejuvenation' or 'designer vaginoplasty,' which lack robust evidence of functional benefit and carry specific risks the patient must be fully counselled about.

Vaginal and perineal plastic surgery addresses several clinically recognised anatomical and functional conditions:

• Post-obstetric perineal body deficiency: Disruption or inadequate primary healing of the perineal body following a vaginal delivery, episiotomy, or perineal tear of any degree. Symptoms include perineal laxity, a gaping introitus, loss of perineal support, dyspareunia, altered sexual sensation, and occasionally rectal symptoms. The deficit is confirmed clinically by demonstrating absence of the normal perineal body, approximation of the fourchette to the anus, and visible separation of the posterior vaginal wall from the perineal structures.
• Introital stenosis (vaginal outlet narrowing): Abnormal narrowing of the vaginal introitus causing apareunia or severe dyspareunia, inability to use tampons, difficulty with gynaecological examination, or urinary stream distortion. Causes include aggressive or poorly healed episiotomy repair, radiation-induced fibrosis (pelvic radiotherapy for cervical or rectal cancer), lichen sclerosus with perineal scarring, post-surgical scarring, or congenital narrowing.
• Vaginismus with structural component: Vaginismus — the involuntary spasm of the vaginal and perineal muscles preventing penetration — is primarily a psychosexual condition managed by pelvic floor physiotherapy and psychosexual therapy. However, when significant structural scarring or introital narrowing contributes to the inability to achieve penetration despite resolution of the psychological component, surgical widening of the introitus (vestibulotomy or introitoplasty) may be incorporated into a multimodal management plan.
• Perineal wound breakdown or chronic perineal scar: Symptomatic non-healing or painful perineal scars from poorly repaired or infected obstetric tears, resulting in chronic dyspareunia, granuloma formation, or skin tags. Surgical revision excises the scar tissue and achieves fresh, anatomical repair.
• Gender-affirming vaginoplasty: In transgender women, vaginoplasty creates a functional neovagina. This is a distinct and specialised procedure described in the relevant section below.

Candidacy for vaginal and perineal plastic surgery requires thorough clinical and psychosexual assessment to confirm structural pathology, establish functional indication, and identify concurrent pelvic floor conditions that may influence outcomes.

Clinical Assessment

• Detailed obstetric and surgical history: Mode and number of deliveries, details of perineal trauma (degree of tear, episiotomy, instrument use), prior perineal repairs, and healing complications. History of pelvic radiotherapy, prior pelvic or perineal surgery, and chronic skin conditions (lichen sclerosus, lichen planus) is essential.
• Functional symptom assessment: Validated instruments (FSFI — Female Sexual Function Index; DSES — Dyspareunia Severity and Effect Scale) quantify the degree of dyspareunia, impact on sexual function, and relationship wellbeing. Bowel function (defecation, faecal incontinence, obstructed defecation) and urinary symptoms are separately assessed as concurrent prolapse or sphincter injury may require simultaneous treatment.
• Perineal and vaginal examination: Clinical inspection and palpation of the perineum quantifies perineal body height, fourchette position, introital calibre, scar quality, and presence of posterior vaginal wall prolapse. POP-Q staging is performed. Anal sphincter integrity is assessed clinically and by anorectal manometry or endoanal ultrasound if faecal urgency or incontinence is present.
• Psychosexual assessment: In all women presenting with sexual pain or vaginismus, psychosexual evaluation is recommended to distinguish primary psychosexual causes (amenable to therapy alone) from structural contributions. Surgery alone is rarely adequate for vaginismus without concurrent psychosexual therapy.
• Pelvic floor physiotherapy trial: All women with dyspareunia, vaginismus, or perineal dysfunction should complete a supervised trial of pelvic floor physiotherapy before surgical intervention is considered, except in cases of clear structural pathology (stenosis, retained scar) where physiotherapy alone is insufficient.

Timing and Readiness

Perineoplasty is optimally performed after childbearing is complete to avoid disruption of the repair by subsequent deliveries. Minimum recommended interval between the last delivery and elective perineoplasty is 6–12 months to allow tissue oedema and bruising to fully resolve and fascial anatomy to stabilise. Local oestrogen therapy for 6–8 weeks pre-operatively is recommended for post-menopausal women to optimise perineal tissue quality.

Several techniques are employed depending on the specific indication, degree of structural deficiency, and concurrent conditions.

1. Perineoplasty (Perineal Body Reconstruction)

The standard procedure for post-obstetric perineal body deficiency. A diamond-shaped or V-shaped incision is made at the perineum and posterior fourchette, excising the scar tissue and identifying the disrupted perineal muscles. The superficial and deep transverse perineal muscles and the bulbocavernosus muscles are dissected laterally, brought to the midline, and approximated with interrupted absorbable sutures (PDS or Vicryl), reconstructing the perineal body and restoring its normal dimensions. The fourchette is advanced and closed, narrowing a gaping introitus to a functional calibre without overcorrection. The technique is modelled on formal obstetric perineal repair but performed electively with proper anaesthesia, exposure, and tissue quality. Success rates for functional improvement exceed 85–90% in experienced hands.

2. Posterior Colporrhaphy Combined with Perineoplasty

When perineal body deficiency coexists with posterior vaginal wall prolapse (rectocele), perineoplasty is performed in continuity with posterior colporrhaphy (see separate guide: Posterior Vaginal Repair). The posterior vaginal skin is incised and the rectovaginal fascia is plicated or defects repaired before the perineal reconstruction. This combined approach addresses both the apical posterior prolapse and the perineal outlet in a single operation.

3. Introitoplasty (Vaginal Outlet Enlargement for Introital Stenosis)

For pathological narrowing of the vaginal introitus due to scarring, radiation injury, or post-surgical fibrosis, the stenotic scar is excised and healthy tissue is advanced to reconstruct a functional opening. Techniques include: posterior V-Y plasty (a flap advancement technique that lengthens the posterior fourchette); Fenton's procedure (horizontal transverse incision at the narrowest point, closed vertically, increasing introital width); or formal excision of the stenotic ring with rotational skin flaps for circumferential stenosis. The approach is tailored to the anatomy of the specific stenosis.

4. Vestibulectomy (Modified or Total)

For vulval vestibulitis syndrome / provoked vestibulodynia — a condition causing severe introital burning and allodynia triggered by touch or penetration — surgical vestibulectomy removes the hypersensitised vestibular mucosa and replaces it with vaginal mucosal advancement. Total vestibulectomy with vaginal advancement has success rates of 60–90% for provoked vestibulodynia in patients who have failed conservative treatment.

5. Gender-Affirming Vaginoplasty

In transgender women, vaginoplasty creates a functional neovagina and vulval anatomy. The two primary techniques are:

• Penile inversion vaginoplasty (PIV): The most common technique. Penile skin is inverted to line the neovaginal cavity; the glans penis forms the neoclitoris. The neovaginal depth is typically 10–14 cm. Requires lifelong daily neovaginal dilation to maintain depth.
• Sigmoid colon vaginoplasty: A segment of sigmoid colon is mobilised and used to line the neovaginal cavity. Provides a self-lubricating mucosa and avoids dilation requirements. Reserved for patients with insufficient penile skin or those who have undergone prior scrotal/penile surgery. More complex with abdominal component.

Gender-affirming vaginoplasty is a specialist procedure performed at dedicated gender surgery centres after fulfilling established criteria including psychological assessment, hormone therapy, and real-life experience as per WPATH Standards of Care.

When appropriately indicated and performed by an experienced pelvic floor or plastic surgeon, vaginal and perineal surgery provides meaningful, durable functional and quality-of-life improvements.

• Relief from dyspareunia: Perineoplasty for post-obstetric perineal deficiency achieves significant or complete resolution of dyspareunia in 70–90% of patients in published series. Correction of structural scarring or narrowing removes the primary mechanical barrier to comfortable intercourse.
• Restoration of perineal anatomy: Reconstruction of the perineal body restores the structural foundation of the pelvic floor, improving support to the posterior vaginal wall and reducing risk of progressive rectocele formation.
• Improvement in sexual wellbeing: Validated sexual function outcomes (FSFI scores) demonstrate significant improvement in sexual satisfaction, arousal, orgasm, and pain subscales following successful repair. Many patients report restoration of sexual confidence, relationship intimacy, and overall wellbeing that had been severely impacted by years of symptoms.
• Resolution of introital stenosis: Introitoplasty achieves reliable widening of a pathological narrowing, allowing normal penetration, tampon use, and gynaecological examination in the majority of patients.
• Correction of cosmetic and functional perineal deformity: Large perineal scars, skin bridges, or granulomas causing chronic irritation, hygiene difficulties, or visible deformity are corrected with simple scar revision under local anaesthesia.
• Gender affirmation and wellbeing (gender-affirming vaginoplasty): For transgender women, vaginoplasty provides profound psychological benefit, significantly improving gender dysphoria scores, depression, anxiety, and quality of life on validated instruments. A 2020 systematic review in Plastic and Reconstructive Surgery confirmed high patient satisfaction rates exceeding 85%.

Vaginal and perineal surgery carries well-recognised risks. The risk profile is generally favourable for standard perineoplasty but increases with more complex procedures.

Intra-Operative Risks

• Rectal injury: Inadvertent entry into the rectum during perineal dissection, particularly where scarring from prior tears has distorted anatomy. Incidence below 1% in elective cases with experienced surgeons. Recognised intra-operatively and repaired immediately.
• Haemorrhage: The perineum is highly vascular; haemostasis requires careful technique. Significant intra-operative bleeding is uncommon in experienced hands.

Early Post-Operative Complications

• Wound infection: Perineal wounds are in proximity to the ano-vulval region; infection occurs in 3–10% of cases. Managed with antibiotics and local wound care. Antibiotic prophylaxis is given peri-operatively.
• Wound breakdown (dehiscence): Partial or complete wound separation, particularly when healing is compromised by constipation, straining, haematoma, or infection. Minor dehiscence may heal secondarily; significant dehiscence requires wound care or re-suturing under local anaesthesia after wound maturation.
• Haematoma: Perineal haematoma occurs in 2–5% of cases; most resolve spontaneously with conservative management.

Late Complications

• Persistent or new dyspareunia: Overcorrection — narrowing the introitus excessively — is the most significant risk of perineoplasty and can cause new or worsened introital dyspareunia. Careful attention to calibre of the introitus at closure (ensuring 2–3 finger breadth width) minimises this risk. Experienced surgeons emphasise functional outcome over maximising narrowing.
• Scar formation: Perineal scars can be tender, indurated, or symptomatic. Scar massage from 6–8 weeks post-operatively and topical treatments help soften the repair. Persistent scar tenderness may respond to topical lignocaine, physiotherapy, or corticosteroid injection.
• Rectovaginal fistula: Rare (<0.5%); abnormal communication between the vagina and rectum resulting in faecal passage per vagina. Requires surgical repair after a healing interval of 3–6 months.
• Neovaginal complications (gender-affirming vaginoplasty): Include neovaginal stenosis (10–20%), failure to maintain neovaginal depth without diligent dilation, wound breakdown (5–15%), fistula formation, hair growth within the neovagina, clitoral numbness or necrosis. Careful pre-operative planning, surgeon experience, and patient compliance with dilation protocols significantly reduce these risks.
• Psychological factors: Surgery does not resolve the psychological component of sexual pain disorders or vaginismus if concurrent psychosexual issues are not addressed. Post-operative psychosexual therapy is an integral part of the recovery plan for these patients.

Recovery from perineoplasty is generally straightforward and well-tolerated. Specific post-operative instructions are critical to optimise wound healing and functional outcomes.

Immediate Post-Operative Period (Days 1–3)

Perineoplasty and simple introitoplasty are often performed as day-case surgery under local anaesthesia or brief general anaesthesia, with discharge on the day of surgery or the following morning. Regional or general anaesthesia is used for more complex repairs or combined posterior colporrhaphy procedures. A urethral catheter may be placed for 12–24 hours. Perineal discomfort is expected and managed with regular oral analgesia (paracetamol, ibuprofen). Ice packs applied to the perineum in the first 24–48 hours reduce swelling and bruising.

Weeks 1–3: Wound Care and Bowel Management

Meticulous wound hygiene is essential. Patients are instructed to rinse the perineum with water after toileting, pat dry gently, and apply a thin layer of antiseptic or emollient as directed. Stool softeners (macrogol, lactulose) are commenced to prevent straining on the repair — constipation and straining are the primary causes of wound breakdown in the early post-operative period. A high-fibre diet (25–30 g/day) and adequate fluid intake (2 L/day) are maintained throughout. Tight or constrictive clothing is avoided. Patients may shower from day 1 but should avoid baths, swimming, and any vaginal insertion (including tampons) for 6–8 weeks.

Return to Activity

Sedentary work can typically resume at 1–2 weeks. Driving should be avoided for 2 weeks. Prolonged sitting on hard surfaces may be uncomfortable for 2–3 weeks; a doughnut cushion or ring cushion can help. Strenuous exercise, heavy lifting (>5 kg), cycling, and penetrative sexual intercourse should be avoided for 6 weeks. After 6 weeks, resumption of sexual activity is guided by symptom comfort and clinical review findings. Pelvic floor physiotherapy commencing at 6 weeks accelerates functional recovery and optimises the perineal repair.

Neovaginal Dilation (Gender-Affirming Vaginoplasty)

Following penile inversion vaginoplasty, lifelong neovaginal dilation is required to prevent stenosis and maintain neovaginal depth. A graduated dilation regimen begins post-operatively in hospital and continues at home with decreasing frequency over 12 months — initially several times daily, reducing to maintenance dilation 3–5 times per week long-term for patients not having regular penetrative intercourse. Failure to maintain the dilation regimen is the primary cause of neovaginal stenosis and depth loss.

Long-Term Follow-Up

Clinical review at 6–8 weeks assesses wound healing, confirms introital calibre, and evaluates initial functional outcomes. A structured follow-up at 3–6 months assesses sexual function, patient satisfaction, and any complications. Physiotherapy follow-up is continued as needed. Long-term annual review monitors for scar complications, recurrence of prolapse in combined procedures, and evolving functional needs.

The cost of vaginal and perineal plastic surgery varies substantially based on procedure complexity, anaesthetic requirement, and healthcare setting.

Perineoplasty and Introitoplasty

• United States: USD 4,000–12,000 (local anaesthetic/outpatient); USD 8,000–20,000 if combined with posterior repair under general anaesthesia
• United Kingdom: GBP 2,500–6,000 private; available on NHS when functional indication is clearly documented (post-obstetric injury, introital stenosis from radiation)
• India: USD 1,200–3,500 at specialist urogynecology or plastic surgery centres
• Thailand: USD 2,000–5,500
• Turkey: USD 1,800–5,000

Gender-Affirming Vaginoplasty

• United States: USD 20,000–50,000 (some insurance coverage under ACA non-discrimination provisions; variable by insurer and state)
• United Kingdom: GBP 10,000–25,000 private; available via NHS Gender Dysphoria Clinics with documented diagnosis and WPATH compliance (waiting lists are long)
• India: USD 5,000–12,000 at specialist gender surgery centres
• Thailand: USD 8,000–18,000 — Thailand is a leading global destination for gender-affirming surgery with highly experienced specialist centres
• Serbia / Czech Republic: USD 7,000–15,000 — prominent European destinations

Insurance Coverage

Coverage for functionally indicated perineoplasty (post-obstetric injury, radiation stenosis, documented dyspareunia) varies by insurer. Elective cosmetic genital procedures are generally not covered. Gender-affirming vaginoplasty coverage varies by country and insurer: many European countries and some US state Medicaid programmes now cover it when WPATH criteria are met.

Non-surgical alternatives should be explored before surgery for most indications. Surgery is most clearly indicated when conservative measures have failed or when structural pathology precludes conservative resolution.

• Pelvic floor physiotherapy: The cornerstone of conservative management for post-obstetric perineal dysfunction, dyspareunia, and vaginismus. A specialist continence or pelvic floor physiotherapist employs targeted exercises, manual therapy, internal scar mobilisation, biofeedback, and electrostimulation to improve muscle function, reduce scar tightness, and restore the pattern of normal muscle coordination. A systematic review in Journal of Sexual Medicine (2019) confirmed high-quality evidence for physiotherapy effectiveness in dyspareunia and vaginismus. Minimum trial of 3–6 months is recommended before surgery is considered for these indications.
• Progressive vaginal dilation therapy: For introital stenosis or vaginismus, a graduated programme of vaginal dilators — used in increasing sizes under guidance of a physiotherapist or psychosexual therapist — can progressively stretch restricted introital tissue and desensitise involuntary muscular spasm. Success rates for achieving functional intercourse with dilation therapy alone are 60–80% for vaginismus when psychological factors are concurrently addressed.
• Psychosexual therapy: For sexual pain disorders, vaginismus, and relationship dysfunction arising from perineal trauma, psychosexual therapy (cognitive behavioural therapy, couple therapy, trauma-focused therapy) is an essential component of management and is often more effective than surgery alone.
• Topical local oestrogen: In peri- and post-menopausal women, genitourinary syndrome of menopause (GSM) — causing vaginal dryness, atrophy, and dyspareunia — responds effectively to topical oestrogen cream or pessaries without surgery. Systemic HRT provides additional benefits. Topical oestrogen should be trialled for at least 3 months before attributing dyspareunia to structural perineal pathology in menopausal women.
• Topical lidocaine gel: For provoked vestibulodynia (vulval vestibulitis), topical lignocaine 5% ointment applied to the vestibule 2–3 minutes before intercourse provides effective symptomatic relief in many women, avoiding or deferring the need for vestibulectomy.
• Fractional CO2 laser (non-ablative vaginal rejuvenation): Fractional CO2 laser applied to the vaginal mucosa (e.g., MonaLisa Touch, FemTouch) stimulates collagen remodelling and improves vaginal mucosal health in postmenopausal women with GSM. Evidence supports modest improvement in dyspareunia and vaginal dryness in short-term trials. Long-term data are limited; the FDA has cautioned against unproven marketing claims for these devices, but they represent a potential adjunct in selected patients.